Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis
Inhaled corticosteroids are important in the management of chronic obstructive pulmonary disease (COPD), but can slightly increase the risk of pneumonia in patients with moderate-to-severe COPD. Patients with circulating eosinophil counts of 2% or more of blood leucocytes respond better to inhaled c...
Main Authors: | Pavord, I, Lettis, S, Anzueto, A, Barnes, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lancet
2016
|
Similar Items
-
Blood eosinophil levels as a biomarker in COPD
by: Brusselle, G, et al.
Published: (2018) -
GLUCOLD, eosinophils and chronic obstructive pulmonary disease
by: Pavord, I
Published: (2018) -
Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma
by: Yuki Abe, et al.
Published: (2023-07-01) -
Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017) -
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018)